This is a Validated Antibody Database (VAD) review about human ACTN4, based on 29 published articles (read how Labome selects the articles), using ACTN4 antibody in all methods. It is aimed to help Labome visitors find the most suited ACTN4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
ACTN4 synonym: ACTININ-4; FSGS; FSGS1

Santa Cruz Biotechnology
mouse monoclonal (A-8)
  • western blot; rat; loading ...; fig 3f
Santa Cruz Biotechnology ACTN4 antibody (Santa, sc-393495) was used in western blot on rat samples (fig 3f). Int J Mol Sci (2019) ncbi
mouse monoclonal (H-2)
  • western blot; human; 1:1000; loading ...; fig 1b
Santa Cruz Biotechnology ACTN4 antibody (Santa, sc-17829) was used in western blot on human samples at 1:1000 (fig 1b). elife (2019) ncbi
mouse monoclonal (A-8)
  • immunocytochemistry; human; loading ...; fig s8a
Santa Cruz Biotechnology ACTN4 antibody (SantaCruz, sc-393495) was used in immunocytochemistry on human samples (fig s8a). J Clin Invest (2017) ncbi
mouse monoclonal (H-2)
  • western blot; mouse; fig 1
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on mouse samples (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (H-2)
  • immunocytochemistry; human; fig 3
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz Biotechnology, sc-17829) was used in immunocytochemistry on human samples (fig 3). BMC Cancer (2016) ncbi
mouse monoclonal (H-2)
  • western blot; human; 1:200; loading ...; fig 6a
Santa Cruz Biotechnology ACTN4 antibody (SantaCruz, sc-17829) was used in western blot on human samples at 1:200 (fig 6a). Oncotarget (2016) ncbi
mouse monoclonal (H-2)
  • western blot; human; fig 5
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz Biotechnology, sc-17829) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
mouse monoclonal (H-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on human samples (fig 2). J Biol Chem (2016) ncbi
mouse monoclonal (H-2)
  • western blot; human; 1:6000; fig s8
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on human samples at 1:6000 (fig s8). BMC Cancer (2015) ncbi
mouse monoclonal (B-12)
  • western blot; human; fig 2
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-166524) was used in western blot on human samples (fig 2). Oncogene (2016) ncbi
mouse monoclonal (H-2)
  • western blot; human; fig 2
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (H-2)
  • western blot; human; fig 2A
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on human samples (fig 2A). Oncotarget (2015) ncbi
mouse monoclonal (H-2)
  • immunocytochemistry; human
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in immunocytochemistry on human samples . Mol Cell Endocrinol (2015) ncbi
mouse monoclonal (H-2)
  • western blot; human; 1:1000
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, H-2) was used in western blot on human samples at 1:1000. Mutat Res (2015) ncbi
mouse monoclonal (LW-M23)
  • western blot; human; fig  3
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz Biotechnology, sc-134236) was used in western blot on human samples (fig  3). Clin Exp Metastasis (2015) ncbi
mouse monoclonal (H-2)
  • western blot; human
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz Biotechnology, sc-17829) was used in western blot on human samples . Colloids Surf B Biointerfaces (2015) ncbi
mouse monoclonal (H-2)
  • western blot; human; fig 1
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on human samples (fig 1). Cancer Discov (2015) ncbi
mouse monoclonal (H-2)
  • western blot; human; fig 5d
In order to suggest that HGF and EGFR signaling mediate ovarian cancer ascites-mediated migration of human peritoneal mesothelial cells, Santa Cruz Biotechnology ACTN4 antibody (santa cruz, sc-17829) was used in western blot on human samples (fig 5d). Int J Cancer (2015) ncbi
mouse monoclonal (B-11)
  • western blot; mouse; fig 2
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, B11) was used in western blot on mouse samples (fig 2). Proc Natl Acad Sci U S A (2014) ncbi
mouse monoclonal (H-2)
  • western blot; human; 1:800
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz, sc-17829) was used in western blot on human samples at 1:800. J Physiol (2014) ncbi
mouse monoclonal (H-2)
  • western blot; human
Santa Cruz Biotechnology ACTN4 antibody (Santa Cruz Biotechnology, H-2) was used in western blot on human samples . Mol Oncol (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR2533(2))
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 4a
Abcam ACTN4 antibody (Abcam, ab108198) was used in immunohistochemistry - paraffin section on mouse samples (fig 4a). Lipids Health Dis (2022) ncbi
domestic rabbit monoclonal (EPR2533(2))
  • western blot; human; loading ...; fig 6h
Abcam ACTN4 antibody (Abcam, ab108198) was used in western blot on human samples (fig 6h). Cell Death Dis (2021) ncbi
domestic rabbit monoclonal (EPR2533(2))
  • western blot; human; loading ...; fig s4b
Abcam ACTN4 antibody (Abcam, ab108198) was used in western blot on human samples (fig s4b). Cell (2019) ncbi
domestic rabbit monoclonal (EPR2533(2))
  • western blot; mouse; loading ...; fig s2d
Abcam ACTN4 antibody (Abcam, ab108198) was used in western blot on mouse samples (fig s2d). Dev Cell (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; rat; 1:200; fig 5
Abcam ACTN4 antibody (Abcam, Ab59468) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 5). Mol Imaging (2018) ncbi
mouse monoclonal (7H6)
  • western blot; human; fig  2
Abcam ACTN4 antibody (Abcam, ab32816) was used in western blot on human samples (fig  2). Cancer Lett (2015) ncbi
mouse monoclonal (7H6)
  • immunocytochemistry; human; fig 2
Abcam ACTN4 antibody (Abcam, ab32816) was used in immunocytochemistry on human samples (fig 2). Mar Drugs (2013) ncbi
Invitrogen
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 4 ug/ml; fig 1
In order to study syndecan-4-mediated podocyte cell-matrix interactions that require N-sulfation of heparan sulfate, Invitrogen ACTN4 antibody (Zymed, 42-1400) was used in immunocytochemistry on mouse samples at 4 ug/ml (fig 1). Am J Physiol Renal Physiol (2016) ncbi
Articles Reviewed
  1. Li G, Lu D, Wang J, Yue S, Tan M, Liu M, et al. ANGPTL3 is involved in kidney injury in high-fat diet-fed mice by suppressing ACTN4 expression. Lipids Health Dis. 2022;21:90 pubmed publisher
  2. Zhang K, Liu D, Zhao J, Shi S, He X, Da P, et al. Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis. Cell Death Dis. 2021;12:554 pubmed publisher
  3. Otani K, Fujioka Y, Okada M, Yamawaki H. Optimal Isolation Method of Small Extracellular Vesicles from Rat Plasma. Int J Mol Sci. 2019;20: pubmed publisher
  4. Stefanius K, Servage K, de Souza Santos M, Gray H, Toombs J, Chimalapati S, et al. Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation. elife. 2019;8: pubmed publisher
  5. Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L, et al. Reassessment of Exosome Composition. Cell. 2019;177:428-445.e18 pubmed publisher
  6. Schell C, Sabass B, Helmstaedter M, Geist F, Abed A, Yasuda Yamahara M, et al. ARP3 Controls the Podocyte Architecture at the Kidney Filtration Barrier. Dev Cell. 2018;47:741-757.e8 pubmed publisher
  7. Jones J, Busi S, Mitchem J, Amos Landgraf J, Lewis M. Evaluation of a Tumor-Targeting, Near-Infrared Fluorescent Peptide for Early Detection and Endoscopic Resection of Polyps in a Rat Model of Colorectal Cancer. Mol Imaging. 2018;17:1536012118790065 pubmed publisher
  8. Rao J, Ashraf S, Tan W, van der Ven A, Gee H, Braun D, et al. Advillin acts upstream of phospholipase C ϵ1 in steroid-resistant nephrotic syndrome. J Clin Invest. 2017;127:4257-4269 pubmed publisher
  9. Ow J, Palanichamy Kala M, Rao V, Choi M, Bharathy N, Taneja R. G9a inhibits MEF2C activity to control sarcomere assembly. Sci Rep. 2016;6:34163 pubmed publisher
  10. Flores Perez A, Marchat L, Rodríguez Cuevas S, Bautista V, Fuentes Mera L, Romero Zamora D, et al. Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC Cancer. 2016;16:379 pubmed publisher
  11. Liu S, Zhou F, Shen Y, Zhang Y, Yin H, Zeng Y, et al. Fluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells. Oncotarget. 2016;7:32876-92 pubmed publisher
  12. Sugar T, Wassenhove McCarthy D, Orr A, Green J, van Kuppevelt T, McCarthy K. N-sulfation of heparan sulfate is critical for syndecan-4-mediated podocyte cell-matrix interactions. Am J Physiol Renal Physiol. 2016;310:F1123-35 pubmed publisher
  13. Black J, Zhang H, Kim J, Getz G, Whetstine J. Regulation of Transient Site-specific Copy Gain by MicroRNA. J Biol Chem. 2016;291:4862-71 pubmed publisher
  14. Monian P, Jiang X. The Cellular Apoptosis Susceptibility Protein (CAS) Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis and Cell Proliferation. J Biol Chem. 2016;291:2379-88 pubmed publisher
  15. Pasini L, Re A, Tebaldi T, Ricci G, Boi S, Adami V, et al. TrkA is amplified in malignant melanoma patients and induces an anti-proliferative response in cell lines. BMC Cancer. 2015;15:777 pubmed publisher
  16. Subbaiah V, Zhang Y, Rajagopalan D, Abdullah L, Yeo Teh N, Tomaić V, et al. E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60. Oncogene. 2016;35:2062-74 pubmed publisher
  17. Ma S, Yin N, Qi X, Pfister S, Zhang M, Ma R, et al. Tyrosine dephosphorylation enhances the therapeutic target activity of epidermal growth factor receptor (EGFR) by disrupting its interaction with estrogen receptor (ER). Oncotarget. 2015;6:13320-33 pubmed
  18. Amente S, Milazzo G, Sorrentino M, Ambrosio S, Di Palo G, Lania L, et al. Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma. Oncotarget. 2015;6:14572-83 pubmed
  19. Piskareva O, Harvey H, Nolan J, Conlon R, Alcock L, Buckley P, et al. The development of cisplatin resistance in neuroblastoma is accompanied by epithelial to mesenchymal transition in vitro. Cancer Lett. 2015;364:142-55 pubmed publisher
  20. Chien P, Lin C, Hsiao L, Yang C. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol Cell Endocrinol. 2015;409:59-72 pubmed publisher
  21. Ambrosio S, Amente S, Napolitano G, Di Palo G, Lania L, Majello B. MYC impairs resolution of site-specific DNA double-strand breaks repair. Mutat Res. 2015;774:6-13 pubmed publisher
  22. Bi Q, Ranjan A, Fan R, Agarwal N, Welch D, Weinman S, et al. MTBP inhibits migration and metastasis of hepatocellular carcinoma. Clin Exp Metastasis. 2015;32:301-11 pubmed publisher
  23. Shen Y, Gao M, Ma Y, Yu H, Cui F, Gregersen H, et al. Effect of surface chemistry on the integrin induced pathway in regulating vascular endothelial cells migration. Colloids Surf B Biointerfaces. 2015;126:188-97 pubmed publisher
  24. Van Rechem C, Black J, Boukhali M, Aryee M, Gräslund S, Haas W, et al. Lysine demethylase KDM4A associates with translation machinery and regulates protein synthesis. Cancer Discov. 2015;5:255-63 pubmed publisher
  25. Matte I, Lane D, Laplante C, Garde Granger P, Rancourt C, Piché A. Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Int J Cancer. 2015;137:289-98 pubmed publisher
  26. Balbas M, Burgess M, Murali R, Wongvipat J, Skaggs B, Mundel P, et al. MAGI-2 scaffold protein is critical for kidney barrier function. Proc Natl Acad Sci U S A. 2014;111:14876-81 pubmed publisher
  27. Lei Q, Pan X, Chang S, Malkowicz S, Guzzo T, Malykhina A. Response of the human detrusor to stretch is regulated by TREK-1, a two-pore-domain (K2P) mechano-gated potassium channel. J Physiol. 2014;592:3013-30 pubmed publisher
  28. Facciuto F, Bugnon Valdano M, Marziali F, Massimi P, Banks L, Cavatorta A, et al. Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein. Mol Oncol. 2014;8:533-43 pubmed publisher
  29. Opsahl J, Ljostveit S, Solstad T, Risa K, Roepstorff P, Fladmark K. Identification of dynamic changes in proteins associated with the cellular cytoskeleton after exposure to okadaic acid. Mar Drugs. 2013;11:1763-82 pubmed publisher